Related Experiment Video
Updated: Jun 21, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Immunobiology of asthma
1Meakins-Christie Labs, McGill University, Montreal, Québec H2X 2P2, Canada. qutayba.hamid@mcgill.ca
Annual Review of Physiology
|July 7, 2009
Summary
Asthma involves airway inflammation driven by immune cells and mediators. This review explores how cytokines and chemokines contribute to asthma
Area of Science:
- Immunology
- Pulmonology
Background:
- Asthma is a chronic airway inflammatory disease involving eosinophils, mast cells, and T helper lymphocytes.
- Inflammatory mediators like cytokines and chemokines trigger bronchoconstriction, mucus secretion, and airway remodeling.
- Allergic asthma's persistent inflammation stems from adaptive immunity and immunological memory to allergens.
Purpose of the Study:
- To review the role of cytokines and chemokines in asthma immunobiology.
- To correlate cytokine/chemokine expression with lung abnormalities in asthma.
- To discuss novel concepts including cytokine roles in airway remodeling and infection interactions.
Main Methods:
- Literature review of immunological and clinical studies on asthma.
- Analysis of cytokine and chemokine involvement in asthma pathogenesis.
- Exploration of adaptive immunity and Th2 cytokine-driven inflammation.
Main Results:
- Cytokines and chemokines are central drivers of asthma inflammation and airway pathology.
- Th2 cytokines play a key role in promoting inflammatory mediator production via positive feedback.
- Immune memory contributes to persistent inflammation and airway damage in allergic asthma.
Conclusions:
- Cytokines and chemokines are critical targets for understanding and managing asthma.
- Further research into cytokine-mediated airway remodeling and infection interactions is warranted.
- Understanding the immunobiology of asthma is essential for developing effective therapies.
More Related Videos
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...